FDA — authorised 6 July 2010
- Application: BLA103293
- Marketing authorisation holder: CHIRON
- Indication: Labeling
- Status: approved
🇺🇸 Proleukin in United States
FDA authorised Proleukin on 6 July 2010
Marketing authorisation
Proleukin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Proleukin approved in United States?
Yes. FDA authorised it on 6 July 2010.
Who is the marketing authorisation holder for Proleukin in United States?
CHIRON holds the US marketing authorisation.